These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32887404)

  • 1. Molecular Mechanisms Underlying the Cardiovascular Toxicity of Specific Uremic Solutes.
    Ravid JD; Chitalia VC
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.
    Ravid JD; Kamel MH; Chitalia VC
    Nat Rev Nephrol; 2021 Jun; 17(6):402-416. PubMed ID: 33758363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
    Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
    Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
    Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
    Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
    Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
    Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic toxins are conditional danger- or homeostasis-associated molecular patterns.
    Sun Y; Johnson C; Zhou J; Wang L; Li YF; Lu Y; Nanayakkara G; Fu H; Shao Y; Sanchez C; Yang WY; Wang X; Choi ET; Li R; Wang H; Yang XF
    Front Biosci (Landmark Ed); 2018 Jan; 23(2):348-387. PubMed ID: 28930551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
    El Chamieh C; Liabeuf S; Massy Z
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis.
    van Ham WB; Cornelissen CM; van Veen TAB
    Acta Physiol (Oxf); 2022 Nov; 236(3):e13888. PubMed ID: 36148604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
    Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.